Segment Information (Table)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of Total Assets by Geographic Area

The Company’s total assets by geographic location are as follows

	December 31,
	2018		2017
Assets
Mainland China	$	272,852	$	289,560
Hong Kong		96,928		9,659
Total Assets	$	369,780	$	299,219

Schedule of Revenues by Product

The Company’s revenues by product are as follows:

	For the year ended December 31,
	2018		2017		2016
Sales
Inactivated hepatitis vaccines	$	63,426	$	37,851	$	20,596
Influenza vaccines		2,028		13,544		9,829
Enterovirus 71 vaccines		162,537		121,284		35,140
H5N1 vaccines		—		—		6,389
Mumps vaccines		1,659		1,667		477
Total Sales	$	229,650	$	174,346	$	72,431

Schedule of Revenues are Attributed to Geographic Locations

The Company’s revenues are attributed to geographic locations as follows:

	For the year ended December 31,
	2018		2017		2016
Sales
Mainland China	$	215,121	$	172,897	$	71,184
Foreign countries		14,529		1,449		1,247
Total Sales	$	229,650	$	174,346	$	72,431